These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11260078)

  • 21. Follow-up studies with sequential bone marrow biopsies in chronic myeloid leukaemia and so-called primary (idiopathic) osteo-myelofibrosis. Evolution of histopathological lesions and clinical course in 40 patients.
    Thiele J; Simon KG; Fischer R; Zankovich R
    Pathol Res Pract; 1988 Aug; 183(4):434-45. PubMed ID: 3186544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone marrow histopathology in chronic myelogenous leukemia (CML)--evaluation of distinctive features with clinical impact.
    Thiele J; Kvasnicka HM; Fischer R
    Histol Histopathol; 1999 Oct; 14(4):1241-56. PubMed ID: 10506940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bone marrow necrosis masquerading as interferon toxicity in chronic myeloid leukemia.
    Chim CS; Ma SK; Lam CK
    Leuk Lymphoma; 1999 Apr; 33(3-4):385-8. PubMed ID: 10221520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Marrow fibrosis, indicator of therapy failure in chronic myeloid leukemia - prospective long-term results from a randomized-controlled trial.
    Buesche G; Hehlmann R; Hecker H; Heimpel H; Heinze B; Schmeil A; Pfirrmann M; Gomez G; Tobler A; Herrmann H; Kappler M; Hasford J; Buhr T; Kreipe HH; Georgii A
    Leukemia; 2003 Dec; 17(12):2444-53. PubMed ID: 14562117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon therapy, but not busulfan restores normal-sized megakaryopoiesis in CML--a comparative histo- and immunomorphometric study.
    Thiele J; Zirbes T; Kvasnicka HM; Niederle N; Dammasch J; Schmidt M; Windecker R; Leder LD; Diehl V; Fischer R
    Anal Cell Pathol; 1996 Jun; 11(1):31-42. PubMed ID: 8844103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erythropoiesis in CML--immunomorphometric quantification, PCNA-reactivity, and influence on survival.
    Thiele J; Hoefer M; Kvasnicka HM; Bertsch HP; Zankovich R; Fischer R
    Hematol Pathol; 1993; 7(4):239-49. PubMed ID: 7906686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apoptosis and proliferation (PCNA labelling) in CML--a comparative immunohistological study on bone marrow biopsies following interferon and busulfan therapy.
    Thiele J; Zirbes TK; Lorenzen J; Kvasnicka HM; Dresbach S; Manich B; Leder LD; Niederle N; Diehl V; Fischer R
    J Pathol; 1997 Mar; 181(3):316-22. PubMed ID: 9155719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotherapy and bone marrow transplantation in the treatment of chronic myelogenous leukemia.
    Kantarjian HM; Talpaz M
    Semin Oncol; 1994 Dec; 21(6 Suppl 14):8-13. PubMed ID: 7992099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prolonged survival in chronic myelogenous leukemia after cytogenetic response to interferon-alpha therapy. The Leukemia Service.
    Kantarjian HM; Smith TL; O'Brien S; Beran M; Pierce S; Talpaz M
    Ann Intern Med; 1995 Feb; 122(4):254-61. PubMed ID: 7825760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized comparison of busulfan and hydroxyurea in chronic myelogenous leukemia: prolongation of survival by hydroxyurea. The German CML Study Group.
    Hehlmann R; Heimpel H; Hasford J; Kolb HJ; Pralle H; Hossfeld DK; Queisser W; Löffler H; Heinze B; Georgii A
    Blood; 1993 Jul; 82(2):398-407. PubMed ID: 8329700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term culture of chronic myeloid leukemia (CML) bone marrow cells.
    Santucci MA; Zaccaria A; Testoni N; Russo D; Zuffa E; Baccarani M; Tura S
    Haematologica; 1991; 76(5):357-62. PubMed ID: 1806437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A histomorphometric analysis of trephine biopsies of bone marrow from 65 patients with chronic myeloid leukemia. Classification of patients into subgroups with different survival patterns.
    Thiele J; Wienhold S; Zankovich R; Fischer R
    Anal Quant Cytol Histol; 1990 Apr; 12(2):103-16. PubMed ID: 2350386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of interferon alpha-induced cytogenetic improvement on survival in chronic myelogenous leukaemia.
    Kloke O; Niederle N; Qiu JY; Wandl U; Moritz T; Nagel-Hiemke M; Hawig I; Opalka B; Seeber S; Becher R
    Br J Haematol; 1993 Mar; 83(3):399-403. PubMed ID: 8485045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic myelogenous leukemia: recent developments in prognostic evaluation and chemotherapy. The German CML Study Group.
    Hehlmann R; Heimpel H; Griesshammer M; Kolb HJ; Heinze B; Hossfeld DK; Wickramanayake PD; Essers U; Thiele J; Georgii A
    Leukemia; 1992; 6 Suppl 3():110S-114S. PubMed ID: 1602805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamics of fibrosis in chronic idiopathic (primary) myelofibrosis during therapy: a follow-up study on 309 patients.
    Thiele J; Kvasnicka HM; Schmitt-Graeff A; Diehl V
    Leuk Lymphoma; 2003 Jun; 44(6):949-53. PubMed ID: 12854892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic myelogenous leukemia: a review.
    Cortes JE; Talpaz M; Kantarjian H
    Am J Med; 1996 May; 100(5):555-70. PubMed ID: 8644769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of chronic myeloid leukemia in chronic phase with autologous stem cell transplantation and alpha-2 interferon: cytogenetic and clinical results.
    Alimena G; Meloni G; de Cuia MR; Rondinelli MB; Lo Coco F; Montefusco E; Mancini M; Pinto R; Nanni M; Cedrone M
    Leuk Lymphoma; 1993; 11 Suppl 1():281-91. PubMed ID: 7902746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of interferon therapy on bone marrow morphology in chronic myeloid leukemia: a cytochemical and immunohistochemical study of trephine biopsies.
    Thiele J; Zirbes TK; Kvasnicka HM; Lorenzen J; Niederle N; Leder LD; Fischer R
    J Interferon Cytokine Res; 1996 Mar; 16(3):217-24. PubMed ID: 8697144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic progress and comparative aspects in chronic myelogenous leukemia (CML): interferon alpha vs. hydroxyurea vs. busulfan and expression of MMTV-related endogenous retroviral sequences in CML. German CML Study Group.
    Hehlmann R; Kister P; Willer A; Simon M; Schenk M; Seifarth W; Papakonstantinou G; Saussele S; Kolb HJ; Ansari H
    Leukemia; 1994 Apr; 8 Suppl 1():S127-32. PubMed ID: 8152279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphometric analysis of myelofibrosis in agnogenic myeloid metaplasia and chronic myelogenous leukemia.
    Ohsaka A; Miura Y; Takahashi A; Yokoyama T
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1991; 60(6):399-405. PubMed ID: 1683056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.